Human Immunity to SARS-CoV-2
Webinar title: "Human immunity to SARS-CoV-2"
In this webinar, Dr. Prahbu Arunachalam reviews a protein biomarker study that revealed how the immune system goes awry leading to severe disease during SARS-CoV-2 infections, as well as identified potential prognostic biomarkers that may serve as therapeutic targets for the disease.
Watch the webinar to learn more about:
- How Dr. Arunachalam and colleagues used a combination of single-cell transcriptomics, plasma proteomics and mass cytometry to study the immune response to severe COVID-19
- The complex immune response to severe SARS-CoV-2 infection, which involves an intricate interplay between the peripheral innate immune response and pro-inflammatory immune response in the lung
- Olink analysis of inflammatory proteins in the blood of COVID-19 patients that identified three novel proteins associated with disease severity which could serve as potential therapeutic targets
Dr. Prahbu Arunachalam
Senior research scientist at the Institute for Immunity, Transplantation, and Infection Operations at Stanford University